BresoTec, a Canadian company based in Toronto, develops and commercializes products for the diagnosis and treatment of sleep apnea and related health conditions.

BresoTec’s first product, BresoDx®, is an innovative and simple device using acoustic and movement analysis technology to diagnose sleep apnea in the home. BresoDx® received regulatory approval from Health Canada in December 2014 and from the European Commission (CE marking) in February 2016.

The BresoDx® technology was developed at Toronto Rehabilitation Institute of the University Health Network (UHN) by Dr. Geoff Fernie, Dr. Douglas Bradley and Dr. Hisham Alshaer. The technology was licensed to BresoTec; founded by UHN and MaRS Innovation in 2012.